Repair that starts within.
Regenerative medicine plays an important role in the medical community and care continuum. By using human cell and tissue products to create an optimal internal healing environment it gives patients and professionals new treatment options that weren’t available just a few years ago.
In order to be effective, you have to put in the work. That’s why Predictive insists on the rigorous research behind every product we develop. By going the extra step to identify the optimal tissue source from which to derive our human cell and tissue products (HCT/Ps), we hope to better support the body’s natural regenerative environment, and aid in its repair. Each of our four signature products has years of research behind it, is thoroughly tested, verified by independent parties and meticulously handled from our own labs to medical offices nationwide. Why? Because our products have a purpose that’s bigger than just business: to help heal everybody.
The importance of protecting what’s important.
In the emerging field of regenerative medicine, Predictive is setting the bar high for processing protocol. The power of our products is in their functionality, but just like all harvested tissue, that functionality can diminish without proper handling. That’s why we process all of our tissues in our FDA-registered lab utilizing proprietary methods that reduce the loss of important scaffolding proteins, growth factors, cytokines and other properties. We then cryogenically freeze the allograft to better preserve viability and even go so far as to provide liquid nitrogen storage containers to our medical partners to ensure the product is kept at -196 degrees Celsius. It’s about minimally processing tissue to preserve and share what matters so we can maximize its potential.
Finding better ways to better repair, replace and restore.
Finding better ways to better repair, replace and restore.
By thoroughly understanding the building blocks at work within the human body, Predictive is able to pinpoint specific tissue sources we believe are best suited for regenerative medicine. Our products are intentionally derived from two tissue sources: the Wharton’s jelly layer of the umbilical cord as well as placental tissue. These rich, potent tissue sources are uniquely able to help protect, cushion and support injured parts of the body as well as aid the optimal regenerative environment.
The power of giving, for the good of everybody.
Our products are ethically sourced from donated birthing tissues such as umbilical cords and placentas from full-term deliveries. Comprehensive medical and social histories of the donor are obtained and tissues are procured, processed, and tested to exceed standards established by FDA.
Products developed to work with—and for—the body.
Through rigorous research, we have identified the Wharton’s jelly layer of the umbilical cord, as well as placental tissue to be the richest sources of regenerative properties. It’s from these two sources that Predictive derives our four key products, each containing a unique blend of cytokines, proteins, growth factors and scaffolding properties: the functional factors involved in the reconstruction, repair, and protection of human tissue. Afterall, we think products that cooperate with your body’s natural functions are the best way to help everybody’s body.
Just as one injury is different from another, Predictive’s products are different from one another. Key contributing factors to regenerative medicine are cytokines, proteins, growth factors and scaffolding properties. All these factors are naturally occurring in all our products, but with varying levels to serve various purposes. Consult the grid to understand the unique concentrations of regenerative factors in our products and to compare them to others in the market.Click here for Product Portfolio Grid
A powerhouse of untapped potential.
Wharton’s jelly is a gelatinous substance in the umbilical cord that provides cushioning and support to the umbilical vein and arteries. Also known to be a rich source of cytokines, growth factors, proteins and mesenchymal stem cells. The unique characteristics associated with Wharton’s jelly have given rise to a wave of new clinical trials to understand its attributes and functions. After extensive research, Predictive believes Wharton’s jelly is unparalleled in its potential in regenerative medicine, perhaps offering a way to better the regenerative process for all people.
Setting a standard every step of the way.
Regenerative medicine truly has the potential to change lives, so we take processing and safety seriously. From donation to administration, Predictive Biotech is unwavering in its commitment to perfecting each and every step. All of our allograft products are prepared utilizing a proprietary mechanical process; two small samples are obtained from each lot with one sent to a third party laboratory for sterility testing and the second used for internal testing to quantify our allograft composition. After the tissue has been processed and packaged into the vials, they are then cryogenically preserved and placed into quarantine. After the sterility testing has been completed and all of the information has been reviewed and approved by our Chief Medical Officer, then--and only then--are our products ready for shipment.
We stand by our products. Period.
In the newly emerging field of regenerative medicine, it’s crucial to work with a company that values transparency and integrity. Predictive believes in the science behind each of its products and believes all the more in informing our partners accurately about them. This ensures all partners and patients are informed of the regenerative factors of each product, and helps maintain a higher standard in the industry.
The crucial step in preserving tissue integrity.
One of the many things that separates Predictive Biotech from other regenerative medicine companies is its absolute insistence on best-in-class handling of its products. It’s not enough to package something and send it to market. To truly help everybody we need to do all we can to ensure functionality. That hinges on our cryopreservation system. Not only do we promptly cryogenically freeze our allografts after processing, but we even go the extra step to deliver special Cryotanks to each of our medical partners, complete with instructions for how to maintain it and its contents. This is essential in offering the most promise to all patients using our products.
AmnioCyte™ is a minimally manipulated human tissue allograft derived from amniotic fluid. AmnioCyte™ is processed to preserve the cytokines, growth factors and proteins in amniotic fluid for homologous use.AmnioCyte Details
AmnioCyte Plus™ is a minimally manipulated human tissue allograft derived from the extracellular matrix of the amniotic membrane. AmnioCyte Plus™ is processed to preserve cytokines, growth factors and scaffolding proteins in the amniotic membrane for homologous use.AmnioCyte Plus Details
PolyCyte™ is a minimally manipulated human tissue allograft derived from the Wharton’s jelly of the umbilical cord. PolyCyte™ is processed to preserve cytokines, growth factors, and proteins of Wharton’s jelly for homologous use.PolyCyte Details
CoreCyte™ is a minimally manipulated human tissue allograft derived from the Wharton’s jelly of the umbilical cord. CoreCyte™ is processed to preserve the integrity of Wharton’s jelly for homologous use and cryogenically preserved.CoreCyte Details
Our Human Cell and Tissue Products (HCT/Ps) are not FDA approved or licensed for the prevention, treatment, diagnosis, mitigation and/or cure of any disease or condition, including COVID-19.